Canmab 440mg - Her2 Targeting Antibody Therapy , Rapid Cell Growth Regulation For Enhanced Breast Cancer Treatment

Canmab 440mg - Her2 Targeting Antibody Therapy , Rapid Cell Growth Regulation For Enhanced Breast Cancer Treatment

Price:

Get Latest Price

In Stock

Product Specifications

Active Ingredient	Trastuzumab
Dosage	440mg
Features	Targeted therapy, HER2 blockade, Cancer treatment, Improved outcomes
Formulation	Injection
Packaging	Vial
Product Name	Canmab 440mg
Storage	Refrigerated
Usage	Treatment of HER2-positive breast cancer
Payment Terms	Others, Cash in Advance (CID)
Main Domestic Market	All India

Product Overview

Key Features

Company Details

Business Type

Exporter, Manufacturer, Service Provider, Supplier

Establishment

1982

Working Days

To

GST NO

09AABCV0200H3ZS

Related Products

More Products From This Seller

Dactovin Tablets - Daclatasvir Inhibitor for Hepatitis C Treatment | First-in-Class NS5A Replication Complex Blocker, Proven Antiviral Support

Dactovin Tablets - Daclatasvir Inhibitor for Hepatitis C Treatment | First-in-Class NS5A Replication Complex Blocker, Proven Antiviral Support

Cadinib - 400mg | High-Quality Performance, Long Shelf Life, Discreet Packaging, Safe Usage

Cadinib - 400mg | High-Quality Performance, Long Shelf Life, Discreet Packaging, Safe Usage

Cimivir L Tablets - Fixed-Dose Combination of Ledipasvir and Sofosbuvir , For Oral Administration Under Medical Guidance

Cimivir L Tablets - Fixed-Dose Combination of Ledipasvir and Sofosbuvir , For Oral Administration Under Medical Guidance

Occupational Health Services

Occupational Health Services

Canmab 440mg - HER2 Targeting Antibody Therapy , Rapid Cell Growth Regulation for Enhanced Breast Cancer Treatment

Canmab 440mg - HER2 Targeting Antibody Therapy , Rapid Cell Growth Regulation for Enhanced Breast Cancer Treatment

Grey Daclafab 60Mg

Grey Daclafab 60Mg

Abstet 250 mg - Hormone Therapy, Adrenal Inhibitor for Prostate Tumor Treatment

Abstet 250 mg - Hormone Therapy, Adrenal Inhibitor for Prostate Tumor Treatment

Alphalan 5mg - Alkylating Agent for Cancer Treatment | Targets Cancer Cell DNA to Inhibit Growth and Division

Alphalan 5mg - Alkylating Agent for Cancer Treatment | Targets Cancer Cell DNA to Inhibit Growth and Division

Cantret 50mg - Anti-Cancer Alkylating Agent, DNA Damaging Chemotherapy Drug for Tumor Resistance

Cantret 50mg - Anti-Cancer Alkylating Agent, DNA Damaging Chemotherapy Drug for Tumor Resistance

Aromasin - 25mg Aromatase Inhibitor , Postmenopausal Estrogen Reduction for Breast Tumor Management

Aromasin - 25mg Aromatase Inhibitor , Postmenopausal Estrogen Reduction for Breast Tumor Management

Seller Details

J

Jubilant Life Sciences Ltd.

GST - 09AABCV0200H3ZS

Gajraula, Uttar Pradesh

Purchase Manager

Mr. Prabhat

Address

Bhartiagram, Tehsil- Gajraula, Dist- JP Nagaar, Gajraula, Uttar Pradesh, 244223, India

Pharmaceutical Ointments & Creams in Gajraula

Report incorrect details

Recommended Products

Canmab 150 Injection

Canmab 150 Injection

Mehadia Tradelinks

Iohexol 350mg - 350mg/ml, Vial Volume 10-50ml | High Purity, Precise Dosage, Sterile Solution, Effective Contrast Agent for Medical Imaging

Iohexol 350mg - 350mg/ml, Vial Volume 10-50ml | High Purity, Precise Dosage, Sterile Solution, Effective Contrast Agent for Medical Imaging

Unimark Remedies Ltd.

Abstet 250 mg - Hormone Therapy, Adrenal Inhibitor for Prostate Tumor Treatment

Abstet 250 mg - Hormone Therapy, Adrenal Inhibitor for Prostate Tumor Treatment

Jubilant Life Sciences Ltd.

Alphalan 5mg - Alkylating Agent for Cancer Treatment | Targets Cancer Cell DNA to Inhibit Growth and Division

Alphalan 5mg - Alkylating Agent for Cancer Treatment | Targets Cancer Cell DNA to Inhibit Growth and Division

Jubilant Life Sciences Ltd.

Cadinib - 400mg | High-Quality Performance, Long Shelf Life, Discreet Packaging, Safe Usage

Cadinib - 400mg | High-Quality Performance, Long Shelf Life, Discreet Packaging, Safe Usage

Jubilant Life Sciences Ltd.

Canmab - 440mg HER2 Targeted Therapy | Advanced Antibody Treatment for HER2/neu Overexpression in Cancer Patients

Canmab - 440mg HER2 Targeted Therapy | Advanced Antibody Treatment for HER2/neu Overexpression in Cancer Patients

Jubilant Lifesciences Ltd

Canmab 440mg - Advanced HER2 Targeted Therapy | Enhanced Cell Growth Regulation

Canmab 440mg - Advanced HER2 Targeted Therapy | Enhanced Cell Growth Regulation

Jubliant Life Sciences (india) Ltd.

Grey Daclafab 60Mg

Grey Daclafab 60Mg

Jubilant Life Sciences Ltd.

Compare With Similar Products

Product Name

Canmab 440mg

CANMAB Trastuzumab 440mg Injection

Trastuzumab Canmab Injection

Buyer Feedback

4

Payment Terms

Others, Cash in Advance (CID)

Telegraphic Transfer (T/T), Cash in Advance (CID), Cheque, Cash Advance (CA)

Cash on Delivery (COD), Cash Advance (CA), Cash in Advance (CID)

Main Domestic Market

All India

All India

All India

Price Or Price Range

26600 INR (Approx.)

6000 INR (Approx.)

Minimum Order Quantity

1 Box/Boxes

100 Box/Boxes

Drug Type

General Medicines

Injection

Physical Form

Liquid

Injection, Other

Recommended For

breast cancer and stomach cancer

Doctor

Dosage

AS PER DOCTOR ADVICE

As Prescribed

Dosage Guidelines

AS PER DOCTOR ADVICE

Recommended By Doctor

Suitable For

Adults

Adults

Quantity

1 Boxes

1 Boxes

Storage Instructions

NORMAL TEMPRATURE

Normal Temperature

Supply Ability

500 BOXES Per Month

1000 Per Month

Delivery Time

10 Days

1 Days

Packaging Details

SINGLE VIAL PACK

Packed In Box

Main Export Market(s)

Australia, North America, Eastern Europe, Western Europe, Middle East, Central America, South America, Asia, Africa

Asia

Sold By

Jubilant Life Sciences Ltd.
Gajraula, Uttar Pradesh

Surety Healthcare
Ahmedabad, Gujarat

Tamizha Medicals
Sivaganga, Tamil Nadu

People Also Viewed

Montelukast Syrup

Insulin Injection

Anesthesia Drugs

Snake Antivenom

Digestive Syrup

Iron Sucrose Injection

Iron Tablets

Glucose Bottle

Meropenem Injection

Glutathione Injection

Pharmaceutical Injection

Antibiotic Tablets

Aspirin Tablets

Japan|China|Taiwan|Thailand|Malaysia|Indonesia| UAE|Saudi Arabia|USA|Iran|Other Countries

Connect with us

Grievances Privacy Policy Terms & Conditions

© 1999-2026 Infocom Network Private Limited. All rights reserved.